Controlling and containing emerging antibiotic-resistant threats and protecting people requires novel and innovative approaches. The human microbiome is a promising area of research for these efforts. Infectious disease experts at the U.S. Centers for Disease Control and Prevention (CDC) and the National Institutes of Health (NIH) recently co-edited a special issue of the Journal of Infectious Diseases (JID) featuring 16 review articles on innovative research of the human microbiome, which is the community of naturally occurring microorganisms in and on our bodies. This work represents ongoing engagement and financial support from CDC’s Antibiotic Resistance (AR) Solutions Initiative to leverage the
